https://www.selleckchem.com/pr....oducts/trastuzumab-d
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited disorder causing life-threatening arrhythmias. Long-term outcome studies of the channelopathy are limited. Objective The aim of the present study was to summarize our knowledge on CPVT patients, including the clinical profile treatment approach and long-term outcome. Methods In this single center study, we retrospectively and prospectively collected data from nine CPVT patients and analyzed them. Results We reviewed nine patients w